Thyroid Cancers Recruiting Phase 2 Trials for Dabrafenib (DB08912)

Also known as: Cancer, Thyroid / Thyroid Cancer / Malignant neoplasm of thyroid gland / Thyroid neoplasms malignant / Thyroid neoplasm malignant / Thyroid gland cancer

IndicationStatusPhase
DBCOND0063689 (Thyroid Cancers)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04544111PDR001 Combination Therapy for Radioiodine-Refractory Thyroid CancerTreatment
NCT04238624Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid CancerTreatment
NCT04554680Clinical Trial in RAI-Refractory Thyroid Carcinoma Evaluating BRAF & MEK Blockade for Re-differentiation TherapyTreatment